LGND - Ligand Corp Annual Revenue Growth (Last Twelve Months)

Graphic logo of Ligand Corp (LGND)

Ligand Pharmaceuticals (LGND) bases its strategy on the aggressive acquisition of intellectual property and third-party startups. This "royalty farm" model enables the company to monetize B2B partnerships with R&D behemoths. A flawless reputation in solubility technologies is confirmed by the annual sales volume growth chart for the TTM, where the value of 1.00 aligns with the current metric, demonstrating the resilience of fundamental sales.

Ligand (LGND): Sales Growth YoY (TTM) from 02/11/2024 to 11/19/2026

Ligand Pharma (LGND) - metric breakdowns and financial figures

- stock price and consensus target price:
Fundamental company valuation:Ligand Corp
Flagship merchandise of Ligand Pharmaceuticals Incorporated

Analyzing business expansion rates is critical for identifying the fundamental drivers of stability for Ligand Pharmaceuticals (LGND). This TTM revenue growth rate relative to the previous year is calculated as the percentage change in total income over a rolling year, allowing systemic trends to be isolated from short-term noise. For a company that accumulates royalties without incurring production costs, this indicator directly reflects the commercial success of partner drugs.

Competitors of Ligand Pharmaceuticals (LGND)

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last 12 Months) AMRX|Sales Growth YoY (Last Twelve Months) Perrigo Company|Trailing Twelve Months Revenue Growth Alvotech ALVO|Sales Growth YoY (TTM) LQDA|GLPG: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) ANIP (ANI Pharmaceuticals, Inc.)|Annual Revenue Growth (Last Twelve Months) MannKind Corp (MNKD)|AMPH: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last 12 Months) TBPH|AQST (Aquestive Corp) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) scPharmaceuticals Inc. (SCPH)|Revenue Growth YoY (Last 12 Months) TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) SXT Pharmaceuticals SXTC|Revenue Dynamics YoY (Last Twelve Months) EPRX|BHST - Sales Growth YoY (Last Twelve Months)|eXoZymes (EXOZ) - Revenue Growth YoY (Last 12 Months)|ORMP: Sales Growth YoY (TTM)|ENTX: Revenue Change YoY (Last 12 Months)|HYFT (ipatherapeutics.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) ABVC BioPharma|Sales Growth YoY (Last Twelve Months) Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Trailing Twelve Months Revenue Growth|RANI - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Synergy CHC SNYR|RLYB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Lexaria (LEXX)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)